Suppr超能文献

病毒感染后慢性阻塞性肺疾病气道微生物组的衍生。

Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.

机构信息

1 National Heart and Lung Institute, Imperial College, London, United Kingdom.

出版信息

Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.

Abstract

RATIONALE

Rhinovirus infection is followed by significantly increased frequencies of positive, potentially pathogenic sputum cultures in chronic obstructive pulmonary disease (COPD). However, it remains unclear whether these represent de novo infections or an increased load of organisms from the complex microbial communities (microbiome) in the lower airways.

OBJECTIVES

To investigate the effect of rhinovirus infection on the airway bacterial microbiome.

METHODS

Subjects with COPD (n = 14) and healthy control subjects with normal lung function (n = 17) were infected with rhinovirus. Induced sputum was collected at baseline before rhinovirus inoculation and again on Days 5, 15, and 42 after rhinovirus infection and DNA was extracted. The V3-V5 region of the bacterial 16S ribosomal RNA gene was amplified and pyrosequenced, resulting in 370,849 high-quality reads from 112 of the possible 124 time points.

MEASUREMENTS AND MAIN RESULTS

At 15 days after rhinovirus infection, there was a sixfold increase in 16S copy number (P = 0.007) and a 16% rise in numbers of proteobacterial sequences, most notably in potentially pathogenic Haemophilus influenzae (P = 2.7 × 10(-20)), from a preexisting community. These changes occurred only in the sputum microbiome of subjects with COPD and were still evident 42 days after infection. This was in contrast to the temporal stability demonstrated in the microbiome of healthy smokers and nonsmokers.

CONCLUSIONS

After rhinovirus infection, there is a rise in bacterial burden and a significant outgrowth of Haemophilus influenzae from the existing microbiota of subjects with COPD. This is not observed in healthy individuals. Our findings suggest that rhinovirus infection in COPD alters the respiratory microbiome and may precipitate secondary bacterial infections.

摘要

背景

鼻病毒感染后,慢性阻塞性肺疾病(COPD)患者的痰培养阳性率和潜在致病率显著升高。然而,目前尚不清楚这些是否代表新的感染,还是下呼吸道复杂微生物群落(微生物组)中微生物负荷的增加。

目的

研究鼻病毒感染对气道细菌微生物组的影响。

方法

将 COPD 患者(n=14)和肺功能正常的健康对照者(n=17)感染鼻病毒。在鼻病毒接种前的基线时和鼻病毒感染后第 5、15 和 42 天收集诱导痰,提取 DNA。扩增细菌 16S 核糖体 RNA 基因的 V3-V5 区,并进行焦磷酸测序,从 124 个可能的时间点中获得了 370849 个高质量的读数。

测量和主要结果

鼻病毒感染后 15 天,16S 拷贝数增加了六倍(P=0.007),变形菌门序列数量增加了 16%,尤其是潜在致病性流感嗜血杆菌(P=2.7×10(-20)),来自于预先存在的群落。这些变化仅发生在 COPD 患者的痰微生物组中,并且在感染后 42 天仍存在。这与健康吸烟者和不吸烟者微生物组表现出的时间稳定性形成了对比。

结论

鼻病毒感染后,COPD 患者的细菌负荷增加,流感嗜血杆菌从现有的微生物群中大量生长。这在健康个体中并未观察到。我们的研究结果表明,鼻病毒感染 COPD 会改变呼吸道微生物组,并可能引发继发性细菌感染。

相似文献

1
Outgrowth of the bacterial airway microbiome after rhinovirus exacerbation of chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1224-31. doi: 10.1164/rccm.201302-0341OC.
2
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.
3
The Sputum Microbiome in Chronic Obstructive Pulmonary Disease Exacerbations.
Ann Am Thorac Soc. 2015 Nov;12 Suppl 2(Suppl 2):S176-80. doi: 10.1513/AnnalsATS.201506-319AW.
4
Oxidative and Nitrosative Stress and Histone Deacetylase-2 Activity in Exacerbations of COPD.
Chest. 2016 Jan;149(1):62-73. doi: 10.1378/chest.14-2637. Epub 2016 Jan 6.
5
Experimental rhinovirus infection as a human model of chronic obstructive pulmonary disease exacerbation.
Am J Respir Crit Care Med. 2011 Mar 15;183(6):734-42. doi: 10.1164/rccm.201006-0833OC. Epub 2010 Oct 1.
8
Human rhinovirus infection during naturally occurring COPD exacerbations.
Eur Respir J. 2014 Jul;44(1):87-96. doi: 10.1183/09031936.00223113. Epub 2014 Mar 13.
9
Airway microbiome dynamics in exacerbations of chronic obstructive pulmonary disease.
J Clin Microbiol. 2014 Aug;52(8):2813-23. doi: 10.1128/JCM.00035-14. Epub 2014 May 21.
10
The lung microbiome and viral-induced exacerbations of chronic obstructive pulmonary disease: new observations, novel approaches.
Am J Respir Crit Care Med. 2013 Nov 15;188(10):1185-6. doi: 10.1164/rccm.201309-1573ED.

引用本文的文献

1
Viruses in bronchiectasis.
ERJ Open Res. 2025 Sep 1;11(5). doi: 10.1183/23120541.01131-2024. eCollection 2025 Sep.
3
A Lymphocyte Subset-Based Prediction Model for Refractory Community-Acquired Pneumonia in Immunocompetent Patients.
Diagnostics (Basel). 2025 Jun 26;15(13):1627. doi: 10.3390/diagnostics15131627.
4
Dual associations of gut and oral microbial networks with kidney transplantation.
mSystems. 2025 Aug 19;10(8):e0025225. doi: 10.1128/msystems.00252-25. Epub 2025 Jul 9.
6
Post-viral lung diseases: the microbiota as a key player.
ERJ Open Res. 2025 Apr 7;11(2). doi: 10.1183/23120541.00560-2024. eCollection 2025 Mar.
7
The impact of environmental factors on respiratory tract microbiome and respiratory system diseases.
Eur J Med Res. 2025 Apr 4;30(1):236. doi: 10.1186/s40001-025-02517-3.
8
Select Airway Specialized Pro-Resolving Mediators Are Associated with Recovery from Non-Viral COPD Exacerbations.
Am J Respir Crit Care Med. 2025 Mar 5;211(5):803-13. doi: 10.1164/rccm.202407-1325OC.

本文引用的文献

1
Comparison of the respiratory microbiome in healthy nonsmokers and smokers.
Am J Respir Crit Care Med. 2013 May 15;187(10):1067-75. doi: 10.1164/rccm.201210-1913OC.
2
Upper airways microbiota in antibiotic-naïve wheezing and healthy infants from the tropics of rural Ecuador.
PLoS One. 2012;7(10):e46803. doi: 10.1371/journal.pone.0046803. Epub 2012 Oct 5.
3
Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012 Dec 1;186(11):1117-24. doi: 10.1164/rccm.201205-0806OC. Epub 2012 Sep 28.
4
Lung microbiology and exacerbations in COPD.
Int J Chron Obstruct Pulmon Dis. 2012;7:555-69. doi: 10.2147/COPD.S28286. Epub 2012 Aug 31.
5
Lung-enriched organisms and aberrant bacterial and fungal respiratory microbiota after lung transplant.
Am J Respir Crit Care Med. 2012 Sep 15;186(6):536-45. doi: 10.1164/rccm.201204-0693OC. Epub 2012 Jul 12.
6
Defective phagocytosis in airways disease.
Chest. 2012 Apr;141(4):1055-1062. doi: 10.1378/chest.11-2348.
7
Decade-long bacterial community dynamics in cystic fibrosis airways.
Proc Natl Acad Sci U S A. 2012 Apr 10;109(15):5809-14. doi: 10.1073/pnas.1120577109. Epub 2012 Mar 26.
8
The lung tissue microbiome in chronic obstructive pulmonary disease.
Am J Respir Crit Care Med. 2012 May 15;185(10):1073-80. doi: 10.1164/rccm.201111-2075OC. Epub 2012 Mar 15.
9
Significance of the microbiome in obstructive lung disease.
Thorax. 2012 May;67(5):456-63. doi: 10.1136/thoraxjnl-2011-201183. Epub 2012 Feb 8.
10
Topographical continuity of bacterial populations in the healthy human respiratory tract.
Am J Respir Crit Care Med. 2011 Oct 15;184(8):957-63. doi: 10.1164/rccm.201104-0655OC. Epub 2011 Jun 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验